Can GLP-1 drugs affect brain health?
Scientists are studying whether medicines such as semaglutide may have effects beyond blood sugar and weight management.
GLP-1 medicines may influence pathways linked to metabolism, inflammation and brain function. Researchers are still studying these effects.
Some studies have reported improvements in certain measures of cognition, but results are not consistent across all studies.
Large Phase 3 trials of oral semaglutide in early Alzheimer’s disease did not demonstrate a clear benefit in slowing clinical progression.
Scientists continue to investigate GLP-1 drugs, cognition, brain inflammation and neurodegenerative diseases.
GLP-1 medicines may have effects on brain health, but more high-quality clinical evidence is needed before they can be considered brain-health treatments.